Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?

---

Copy For Citation

Senturk A., YILMAZEL UÇAR E., BERK S., ÖZLÜ T., Altinsoy B., Dabak G., ...More

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.22, no.4, pp.395-399, 2016 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 22 Issue: 4
• Publication Date: 2016
• Doi Number: 10.1177/1076029614564863
• Journal Name: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.395-399
• Karadeniz Technical University Affiliated: Yes

Abstract

Purpose: The role of low-molecular-weight heparin (LMWH) in managing nonmassive pulmonary embolism (PE) is well known. In unstable cases, especially after thrombolytic therapy for massive PE, unfractionated heparin (UFH) is preferred for PE management. This study aimed to investigate the effectiveness and safety of LMWH after thrombolytic therapy.